Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LENZ Therapeutics (LENZ) Common Equity: 2022

Historic Common Equity for Therapeutics (LENZ) over the last 1 years, with Dec 2022 value amounting to $296.3 million.

  • Therapeutics' Common Equity fell 35.53% to $204.0 million in Q3 2023 from the same period last year, while for Sep 2023 it was $204.0 million, marking a year-over-year decrease of 35.53%. This contributed to the annual value of $296.3 million for FY2022, which is N/A change from last year.
  • Therapeutics' Common Equity amounted to $296.3 million in FY2022.
  • Therapeutics' 5-year Common Equity high stood at $296.3 million for FY2022, and its period low was $296.3 million during FY2022.
  • Its 1-year average for Common Equity is $296.3 million, with a median of $296.3 million in 2022.